Breaking
Hall Bookings

Nutritional supplements tested to prevent TB in Indonesia

By Keisya Oktaviani 2 min read
Nutritional supplements tested to prevent TB in Indonesia - nutritional supplements
According to the World Health Organization’s Global TB Report 2026, TB remains the deadliest infectious disease globally, causing approximately 1.13 million deaths in 2025.

The PHOTON study, launched in October 2026, involves 78,400 individuals, with more than 42,000 participants from Indonesia and the rest from Tanzania.

The five-year trial aims to determine if specific supplements can break the link between undernutrition and active TB. Indonesia, which has the world’s second-highest TB burden, is central to this potential breakthrough.

According to the World Health Organization’s Global TB Report 2026, TB remains the deadliest infectious disease globally, causing approximately 1.13 million deaths in 2025. That year, around 10.6 million people developed TB, with an estimated 2.2 million cases going undiagnosed or unreported. The global incidence rate decreased by only 1.6%, falling short of the pace needed to meet international goals to end TB.

Read Also: AI tools risk erasing brand differentiation and trust

Indonesia accounts for about 10% of global TB cases, second only to India’s 25%. With an estimated 1.08 million cases in 2024, or 382 cases per 100,000 people, the country faces a significant challenge in reaching its goal of eliminating TB by 2030. This target requires reducing the incidence rate to 65 cases per 100,000.

The PHOTON study was presented at the “State of TB Innovation” expert media briefing, organized by the Gates Foundation in November 2026. This briefing took place ahead of the International Union Against Tuberculosis and Lung Disease’s World Conference on Lung Health, held in Rio de Janeiro, Brazil.

New TB Vaccine Development and Screening Efforts

A joint Indonesia-Tanzania clinical trial is testing whether targeted nutritional supplements can prevent tuberculosis (TB) among people exposed to the disease at home, as the country with the world’s second-highest TB burden puts more than 42,000 of its own citizens at the center of a potential breakthrough.

Keisya Oktaviani

Leave a Reply

Your email address will not be published. Required fields are marked *